๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Rationale: The purpose is to evaluate whether non-invasive in vivo imaging ...
Status
Completed
Location
University Medical Center Groningen
Start Date
2016-02
Trial ID
NCT02697032
Treatments Being Tested
Prostate cancer represents a significant health problem in the United State...
Status
Terminated
Location
Wake Forest University Health Sciences
Start Date
2012-11
Trial ID
NCT01724619
Treatments Being Tested
The purpose of this study is to see whether 18F-FDHT PET/MRI scans are an e...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-24
Trial ID
NCT06145399
Knowledge of breast cancer estrogen receptor (ER) expression is of major im...
Status
Completed
Location
VU Medical Center
Start Date
2014-08
Trial ID
NCT01988324
Treatments Being Tested
The purpose of this study is to test the ability of a new PET scan radiotra...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-11
Trial ID
NCT02297386
Treatments Being Tested
This is a concise single arm, feasibility study, which will be executed in ...
Status
Terminated
Location
UMCG
Start Date
2022-11-10
Trial ID
NCT05156606
Treatments Being Tested
Patients suffering either from newly diagnosed very high risk locally advan...
Status
Completed
Location
Medical University of Vienna
Start Date
2020-02-01
Trial ID
NCT05109884
Treatments Being Tested
This study will use PET scans, which is a type of x-ray test that uses a ra...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Consent Only)
Start Date
2003-02
Trial ID
NCT00588185
Treatments Being Tested
Depending on the cohort of the study the diagnostic and prognostic accuracy...
Status
Withdrawn
Location
Medical University of Vienna
Start Date
2022-04
Trial ID
NCT05245435
Treatments Being Tested